PEP HIV (Human Immunodeficiency Virus), Belize - HIV Prevention Treatment
PEP HIV (Human Immunodeficiency Virus), Belize - HIV Prevention Treatment @pephiv_com: Within 3 days of unprotected sex, stop HIV infection with HIV PEP (post-exposure prophylaxis) treatment, Belize - Private and confidential service.
Keywords: PEP HIV (Human Immunodeficiency Virus) Belize, Belize PEP HIV (Human Immunodeficiency Virus), PEP HIV (Human Immunodeficiency Virus).
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: PEP HIV (Human Immunodeficiency Virus), Belize - HIV Prevention Treatment
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Budget airlines based in Singapore: Budget airlines operating in Singapore:
Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.
Lactoferrin levels in gingival crevicular fluid and saliva of HIV‐infected patients with chronic periodontitis
Tue, 21 Oct 2014 21:06:12 +0100 | Journal of Investigative and Clinical Dentistry
ConclusionThe data indicate that LF levels in the GCF and saliva are not different between HIV‐infected and noninfected patients with chronic periodontitis. (Source: Journal of Investigative and Clinical Dentistry)
LabCorp launches test to help guide drug treatments for HIV patients
Tue, 21 Oct 2014 15:58:00 +0100 | bizjournals.com Health Care:Hospitals headlines
Burlington-based LabCorp is launching the first test of its kind to help doctors optimize the drug regimens they rely on for treating HIV patients.
Ethiopia: Toil Here
Tue, 21 Oct 2014 09:08:49 +0100 | AllAfrica News: HIV-Aids and STDs
[Addis Fortune]One of the major aspects of Addis Abeba subject to criticism is the lack of appropriate public toilets. This seems a good start, inside Megenagna Square, where many people take taxis and some trade. The service provider is a union of HIV positive and disabled people, totalling 16 individuals in all. They give services from seven in the morning to eight thirty in the evening, charging 50 cents. These people wear a badge stamped "sew ale" in Amharic, which literally means "there is someone" - a phrase used w (Source: AllAfrica News: HIV-Aids and STDs)
Tanzania: Call for Cut of HIV/Aids Prevalence in Key Groups
Tue, 21 Oct 2014 08:47:56 +0100 | AllAfrica News: HIV-Aids and STDs
[Daily News]ALTHOUGH the nation has recorded impressive success in fighting HIV and AIDS in the country, the disease's prevalence is still high in key population groups. (Source: AllAfrica News: HIV-Aids and STDs)
Nigeria: Elimination of Mother-to-Child HIV Transmission Is Crucial to the MDGs - - Idoko
Tue, 21 Oct 2014 07:21:10 +0100 | AllAfrica News: HIV-Aids and STDs
[Vanguard]The National Agency for the Control of AIDS, NACA, has described the upcoming launch of National Plan for the country's Elimination of Mother-to-Child Transmission of HIV, eMTCT, initiative as being in line with the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. (Source: AllAfrica News: HIV-Aids and STDs)
[Newsdesk] Research brief
Tue, 21 Oct 2014 06:15:25 +0100 | The Lancet Infectious Diseases
30 years after AIDS first emerged in the USA, the geographical source and early dissemination of HIV-1 in the human population remains controversial. A new evolutionary analysis of HIV-1 sequence data from central Africa suggests that the HIV-1 group M viruses originated in Kinshasa (Democratic Republic of the Congo) in the early 1920s and then, because the city was an important commercial transportation hub, spread across central Africa. An exponential increase in group M infections after 1960 suggests that post-independence changes in sexual behaviour in and around Kinshasa might have driven the epidemic growth of the HIV-1 group M pandemic. (Source: The Lancet Infectious Diseases)
Government prosecutes alleged scientific fraud on AIDS research
Tue, 21 Oct 2014 03:39:18 +0100 | CNN.com - Health
If government prosecutors are right, a former top researcher at Iowa State University is guilty of brazen scientific fraud-actions which a criminal complaint says have cost taxpayers nearly $15 million. (Source: CNN.com - Health)
A Novel Gas Chromatographic Method for Determination of Malondialdehyde from Oxidized DNA
Mon, 20 Oct 2014 20:43:39 +0100 | Springer protocols feed by Biochemistry
Malondialdehyde (MA) is known to form from various lipids upon oxidation as one of secondary oxidation products. Determination of MA formed from lipid peroxidation has been used to examine occurrence of oxidative damages associated with many diseases, such as cancer, Alzheimer’s, arthritis, inflammation, diabetes, atherosclerosis, and AIDS as well as aging. Analysis of MA is, however, extremely difficult because it is highly reactive and readily polymerized and forming adducts with biological substances such as proteins, phospholipids, and DNA (Shibamoto, J Pharm Biomed Anal 41:12–25, 2002). Gas chromatographic method using stable derivative, 1-methylpyrazole was advanced and has been successfully used to analyze MA in various lipids and lipid-rich foods. This method was also a...
Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial.
Mon, 20 Oct 2014 17:05:04 +0100 | AIDS Research and Therapy
CONCLUSION: We conclude that the intensification of a Protease Inhibitor regimen with Maraviroc and Raltegravir does not impact the blood proviral DNA reservoir of HIV but can decrease the cell-associated HIV RNA, the CD8 activation and has a possible impact on rectal proviral HIV DNA in some patients.
Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
Mon, 20 Oct 2014 17:05:04 +0100 | AIDS Research and Therapy
CONCLUSION: Modest lipid elevations were observed in African patients on predominantly LPV/r + NNRTI-based second-line regimens. Routine lipid monitoring during second-line ART regimens may not be warranted in this setting but individual cardiovascular risk assessment should guide practice.